Medicine, Made For You

Somewhere in the history of every approved therapy is a clinical trial, and somewhere in that trial is an average. A treatment arm outperforms a placebo arm by a margin that clears the conventional bar for statistical significance, a paper gets published, and a drug reaches the market carrying that population-level result as its credential.

What that average doesn't tell you is which side of it you'd land on. Inside almost every treatment arm are people who responded well, people for whom nothing much changed, and people who didn't tolerate it — three different experiences, folded into one number. The average patient the trial describes doesn't correspond to any single real person in the room.

Why "personalized" has meant less than it sounds like

The phrase "personalized medicine" has been used for years to describe things that are real and useful but narrower than the phrase implies — genotyping that flags a known drug interaction, dosing adjusted for body weight or kidney function. Valuable, and still fundamentally population-based: you're sorted into a slightly smaller population, and then treated against that smaller population's average instead of the whole population's.

What we mean by it is closer to the literal meaning of the phrase: reasoning that starts from an individual's own context — their genetics, their measured biological signals, how their own trajectory is unfolding over time — rather than starting from a population average and making incremental adjustments to it.

What that actually requires

Getting there requires two things most conventional approaches don't have. The first is a way of representing biological signaling that's rich enough to hold individual variation — not just "this patient has condition X" but how their specific signaling network is behaving, relative to what's typical. The second is continuous information: a single visit's worth of data can tell you where someone is right now, but not how they're trending, and trajectory is often more informative than any single snapshot.

This is the thesis behind Instructional Medicine as a research direction: build the evidence-aware reasoning layer first — a system that can hold individual context instead of collapsing it into a population average — so that as richer, continuous biological data becomes available, there's already an architecture built to use it meaningfully rather than force it back into an average it was never meant to fit.